Sort   by:  
 Page size 
UnknownSerum androgens as prognostic biomarkers in castration-resistant prostate cancer: results from an analysis of a randomized phase III trial.
Not available
S-EPMC5569674 | biostudies-literature
UnknownRadiographic progression-free survival as a response biomarker in metastatic castration-resistant prostate cancer: COU-AA-302 results.
Not available
S-EPMC4881370 | biostudies-literature
UnknownCabozantinib in chemotherapy-pretreated metastatic castration-resistant prostate cancer: results of a phase II nonrandomized expansion study.
Not available
S-EPMC4383838 | biostudies-literature
UnknownEffect on Overall Survival of Locoregional Treatment in a Cohort of De Novo Metastatic Prostate Cancer Patients: A Single Institution Retrospective Analysis From the Royal Marsden Hospital.
Not available
S-EPMC5647264 | biostudies-literature
UnknownSerial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration.
Not available
S-EPMC4580992 | biostudies-literature
UnknownAnalytical Validation and Clinical Qualification of a New Immunohistochemical Assay for Androgen Receptor Splice Variant-7 Protein Expression in Metastatic Castration-resistant Prostate Cancer.
Not available
S-EPMC5015575 | biostudies-literature
UnknownElucidating Prostate Cancer Behaviour During Treatment via Low-pass Whole-genome Sequencing of Circulating Tumour DNA.
Not available
S-EPMC8329366 | biostudies-literature
UnknownDocetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers.
Not available
S-EPMC5995869 | biostudies-literature
UnknownAndrogen receptor splice variant-7 expression emerges with castration resistance in prostate cancer.
Not available
S-EPMC6307949 | biostudies-literature
UnknownCharacterizing CDK12-Mutated Prostate Cancers.
Not available
S-EPMC7855716 | biostudies-literature
Sort   by:  
 Page size